Ethinyl estradiol, Norethindrone

Norethindrone and Ethinyl Estradiol (7/14)

0.035MG,0.035MG; 0.5MG,1MG tabletUnited StatesNot marketedAuthorised 24 Sept 1991

In other countries

The same active substances on other registers, the same brand first.

Brevicon 0.5/35 Tablets (21-Day Pack)Canada · 0.035 MG + 0.5 MG · Tablet · Pfizer Canada UlcSame form
Brevicon 0.5/35 Tablets (28-Day Pack)Canada · .035 MG + .5 MG · Tablet · Pfizer Canada UlcSame form
Brevicon 1/35 Tablets (21-Day Pack)Canada · 0.035 MG + 1 MG · Tablet · Pfizer Canada UlcSame form
AnyNew Zealand · Tab 35 mcg with norethisterone 500 mcgSame form
AnyNew Zealand · Tab 35 mcg with norethisterone 1 mgSame form
Brevinor 1/28New Zealand · Tab 35 mcg with norethisterone 1 mg and 7 inert tabSame form
PrimosistonBrazil · União Química Farmacêutica Nacional S/ASame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ethinyl estradiol, Norethindrone

Norethindrone and Ethinyl Estradiol (7/14)

0.035MG,0.035MG; 0.5MG,1MG tabletUnited StatesNot marketedAuthorised 24 Sept 1991

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

acetato de noretisterona + etinilestradiolBrazil · MCG Industria Farmaceutica e Importaçao Ltda

CiclovulonBrazil · Sanval Comercio e Industria Ltda

Ortho-Novum 1/35Taiwan · 錠劑 · 嬌生股份有限公司

Ovysmen* TabletsTaiwan · 錠劑 · 嬌生股份有限公司

Trinovum Oral Contraceptive TabletsTaiwan · 錠劑 · 嬌生股份有限公司

Packs

Pack	Code	Status
ETHINYL ESTRADIOL 0.035MG,0.035MG; NORETHINDRONE 0.5MG,1MG	ANDA071041-001	Discontinued

Documents

The official texts, at the regulator.

Register entryFDA

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration (Drugs@FDA) and openFDA drug labels

Source: U.S. Food and Drug Administration, Drugs@FDA and openFDA drug labels (imported 10 June 2026). Not endorsed by the FDA.

Licence: Public domain (U.S. Government work); openFDA terms · Added 10 Jun 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Ethinyl estradiol, Norethindrone
Strength: 0.035MG,0.035MG; 0.5MG,1MG
Dosage form: tablet
Route: oral-21
Register: United States (FDA)
Status: Not marketed
Status in the register: Discontinued
Authorised: 24 Sept 1991
Registration: ANDA 71041
Marketing authorisation holder: Watson Labs Teva
Procedure: ANDA (generic)

Alyacen 777Ethinyl estradiol + Norethindrone · 0.75MG; 0.035MG, 1MG; 0.035MG · tabletUnited States

AranelleEthinyl estradiol + Norethindrone · 0.035MG,0.035MG,0.035MG; 0.5MG,1MG,0.5MG · tabletUnited States

Aurovela 1/20Ethinyl estradiol + Norethindrone · 0.02MG; 1MG · tabletUnited States

Aurovela 1.5/30Ethinyl estradiol + Norethindrone · 0.03MG; 1.5MG · tabletUnited States

Aurovela 24 FeEthinyl estradiol + Norethindrone · 0.02MG; 1MG · tabletUnited States

Aurovela Fe 1/20Ethinyl estradiol + Norethindrone · 0.02MG; 1MG · tabletUnited States

Aurovela Fe 1.5/30Ethinyl estradiol + Norethindrone · 0.03MG; 1.5MG · tabletUnited States

Balziva-28Ethinyl estradiol + Norethindrone · 0.035MG; 0.4MG · tabletUnited States

Blisovi 24 FeEthinyl estradiol + Norethindrone · 0.02MG; 1MG · tabletUnited States

Blisovi Fe 1.5/30Ethinyl estradiol + Norethindrone · 0.03MG; 1.5MG · tabletUnited States